Stonebridge Capital Management Raised Merck & Company (MRK) Stake by $599,013; Stock Price Rose; American Century Companies Has Lifted Its Callon Pete Co Del (CPE) Holding by $1.77 Million

June 21, 2018 - By Moses P. Lee

Merck & Co., Inc. (NYSE:MRK) Logo

American Century Companies Inc increased its stake in Callon Pete Co Del (CPE) by 24.51% based on its latest 2018Q1 regulatory filing with the SEC. American Century Companies Inc bought 136,274 shares as the company’s stock rose 7.55% while stock markets declined. The institutional investor held 692,223 shares of the oil & gas production company at the end of 2018Q1, valued at $9.17M, up from 555,949 at the end of the previous reported quarter. American Century Companies Inc who had been investing in Callon Pete Co Del for a number of months, seems to be bullish on the $2.33 billion market cap company. The stock decreased 5.19% or $0.56 during the last trading session, reaching $10.23. About 4.75M shares traded. Callon Petroleum Company (NYSE:CPE) has declined 0.42% since June 21, 2017 and is downtrending. It has underperformed by 12.99% the S&P500. Some Historical CPE News: 30/05/2018 – Callon Petroleum Co Announces Closing of Common Stk Offering and Full Exercise of Over-allotment Option to Purchase Additional Shrs; 06/04/2018 – CALLON PETROLEUM AMENDS CREDIT FACILITY, EXPANDS BORROWING BASE; 24/05/2018 – Callon Petroleum Company Announces Ward County Acquisition; 31/05/2018 – Callon Petroleum Company Announces Launch of $300 Million Senior Unsecured Notes Offering; 06/04/2018 – CALLON PETROLEUM CO – THE AMENDMENT EXTEND MATURITY DATE OF CREDIT FACILITY BY ONE YEAR TO MAY 25, 2023; 24/05/2018 – CALLON UNIT TO BUY ACREAGE FOR $570M FROM CIMAREX ENERGY; 09/04/2018 – Callon Petroleum at Group Dinner Hosted By SunTrust Today; 04/04/2018 – Callon Petroleum Access Event Set By Stephens Inc. for Apr. 11; 21/05/2018 – Callon Petroleum Presenting at Barclays Conference Tomorrow; 24/05/2018 – CALLON REPORTS WARD COUNTY PURCHASE

Stonebridge Capital Management Inc increased its stake in Merck & Company (MRK) by 17.62% based on its latest 2018Q1 regulatory filing with the SEC. Stonebridge Capital Management Inc bought 10,509 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 70,153 shares of the health care company at the end of 2018Q1, valued at $4.01 million, up from 59,644 at the end of the previous reported quarter. Stonebridge Capital Management Inc who had been investing in Merck & Company for a number of months, seems to be bullish on the $164.22B market cap company. The stock decreased 0.39% or $0.24 during the last trading session, reaching $61.04. About 5.76 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 21, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 07/03/2018 – Merck KGaA, Darmstadt, Germany, Announces Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis; 15/04/2018 – Merck: Safety Profile of Keytruda Consistent With Previous Trials of Patients With Advanced Melanoma; 01/05/2018 – MERCK & CO 1Q ADJ EPS $1.05, EST. $1; 25/05/2018 – IMFINZI(R) (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer; 16/04/2018 – Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell; 08/03/2018 – Eisai teams with Merck to boost sales of cancer drug; 25/04/2018 – HPV Vaccine Market 2022 Demand, Key Players- Merck and Co., GlaxoSmithKline; 25/04/2018 – CAFC: GILEAD SCIENCES, INC. v. MERCK & CO., INC. [OPINION] – Appeal #16-2302 – 2018-04-25; 10/04/2018 – BerGenBio Completes Recruitment Into First Stage of Phase Il NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®; 21/03/2018 – Britain’s use of copycat biotech drugs takes off while U.S. lags

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) has “Market Perform” rating given on Monday, July 18 by BMO Capital Markets. The rating was upgraded by Barclays Capital on Tuesday, December 1 to “Overweight”. The stock has “Hold” rating by Jefferies on Monday, February 26. The firm has “Buy” rating by Bryan Garnier & Cie given on Friday, January 13. The stock of Merck & Co., Inc. (NYSE:MRK) has “Equal-Weight” rating given on Monday, October 30 by Morgan Stanley. BMO Capital Markets maintained Merck & Co., Inc. (NYSE:MRK) rating on Wednesday, February 14. BMO Capital Markets has “Outperform” rating and $65 target. The firm has “Market Perform” rating by Leerink Swann given on Monday, October 30. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Friday, March 23 with “Hold” rating. The stock has “Underperform” rating by Jefferies on Monday, December 19. The stock has “Hold” rating by Jefferies on Friday, April 13.

Investors sentiment increased to 1 in 2018 Q1. Its up 0.06, from 0.94 in 2017Q4. It improved, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. Central Securities Corporation owns 1.8% invested in Merck & Co., Inc. (NYSE:MRK) for 200,000 shares. Lenox Wealth Inc invested in 1,896 shares. Intact Investment Mgmt Incorporated holds 0.55% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 260,400 shares. Dt Investment Prtnrs Lc owns 0.04% invested in Merck & Co., Inc. (NYSE:MRK) for 4,376 shares. Hermes Invest Mngmt Ltd accumulated 240,526 shares. Guinness Asset Mngmt has invested 2.19% in Merck & Co., Inc. (NYSE:MRK). Green Square Capital Ltd Liability Company stated it has 1.24% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Brighton Jones Lc reported 0.18% in Merck & Co., Inc. (NYSE:MRK). 33,886 are held by First City Cap. Bingham Osborn Scarborough Ltd Liability has 5,084 shares for 0.03% of their portfolio. Fisher Asset Management Limited Co stated it has 8.26 million shares. Choate Inv holds 0% in Merck & Co., Inc. (NYSE:MRK) or 68,607 shares. Cap Wealth Planning Lc invested 0.28% in Merck & Co., Inc. (NYSE:MRK). Veritas Invest Mngmt Llp reported 2,200 shares. Asset Management One Limited has 0.55% invested in Merck & Co., Inc. (NYSE:MRK) for 4.50M shares.

More important recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “Johnson & Johnson: Strong Company, But Won’t Fit In Most Portfolios” on June 21, 2018, also Seekingalpha.com published article titled: “Key events next week – healthcare”, Seekingalpha.com published: “Alzheimer’s Disease: A History Of Drug Failures” on June 19, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) was released by: Fool.com and their article: “Better Buy: Celgene Corporation vs. Merck” with publication date: June 19, 2018.

Stonebridge Capital Management Inc, which manages about $462.82M and $273.23M US Long portfolio, decreased its stake in Williams Sonoma Inc (NYSE:WSM) by 7,610 shares to 70,320 shares, valued at $3.38M in 2018Q1, according to the filing.

Among 32 analysts covering Callon Petroleum (NYSE:CPE), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Callon Petroleum had 97 analyst reports since July 21, 2015 according to SRatingsIntel. As per Monday, July 17, the company rating was maintained by Northland Capital. The stock of Callon Petroleum Company (NYSE:CPE) has “Outperform” rating given on Thursday, November 5 by FBR Capital. UBS initiated it with “Buy” rating and $16 target in Thursday, March 23 report. The firm has “Buy” rating given on Thursday, August 24 by RBC Capital Markets. The firm has “Buy” rating by Canaccord Genuity given on Thursday, September 8. Citigroup maintained Callon Petroleum Company (NYSE:CPE) on Thursday, August 11 with “Neutral” rating. The rating was upgraded by Seaport Global on Wednesday, March 30 to “Buy”. The firm earned “Overweight” rating on Wednesday, April 26 by Barclays Capital. The company was initiated on Tuesday, October 13 by JP Morgan. Jefferies maintained the stock with “Buy” rating in Tuesday, January 30 report.

American Century Companies Inc, which manages about $98.44 billion US Long portfolio, decreased its stake in Red Hat Inc (NYSE:RHT) by 144,545 shares to 944,054 shares, valued at $141.15 million in 2018Q1, according to the filing. It also reduced its holding in F5 Networks Inc (NASDAQ:FFIV) by 11,551 shares in the quarter, leaving it with 51,234 shares, and cut its stake in Douglas Emmett Inc (NYSE:DEI).

Another recent and important Callon Petroleum Company (NYSE:CPE) news was published by Seekingalpha.com which published an article titled: “Callon’s Permian Purchase: Ill-Timed” on May 28, 2018.

Investors sentiment decreased to 1.16 in Q1 2018. Its down 0.25, from 1.41 in 2017Q4. It dived, as 19 investors sold CPE shares while 93 reduced holdings. 38 funds opened positions while 92 raised stakes. 259.41 million shares or 0.39% more from 258.40 million shares in 2017Q4 were reported. Kennedy Cap Mgmt accumulated 1.76 million shares. Quantitative Systematic Strategies Limited Liability Com invested in 46,704 shares or 0.13% of the stock. Moreover, Lenox Wealth Management has 0% invested in Callon Petroleum Company (NYSE:CPE) for 771 shares. Hodges Capital Mgmt invested in 0.05% or 48,000 shares. Miller Howard accumulated 281,118 shares. Rhumbline Advisers accumulated 367,946 shares. Guggenheim Capital Lc accumulated 106,725 shares. Moreover, Ranger Mgmt LP has 1.44% invested in Callon Petroleum Company (NYSE:CPE). Dana Invest Advsr reported 153,731 shares. Assetmark has 0% invested in Callon Petroleum Company (NYSE:CPE) for 661 shares. Federated Pa invested in 1.06 million shares. Cubist Systematic Strategies reported 14,654 shares. Advantus Mngmt has invested 0.01% in Callon Petroleum Company (NYSE:CPE). City Hldgs Com stated it has 0% of its portfolio in Callon Petroleum Company (NYSE:CPE). Ameritas Inv Partners owns 0.05% invested in Callon Petroleum Company (NYSE:CPE) for 77,942 shares.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Moses P. Lee

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: